Literature DB >> 13446374

Some pharmacological actions of four synthetic analogues of oxytocin.

B BERDE, W DOEPFNER, H KONZETT.   

Abstract

Four structural analogues of oxytocin were investigated with regard to their oxytocic, milk-ejecting, pressor and diuretic/antidiuretic effects. In three of them the isoleucyl group of oxytocin was replaced by a phenylalanyl, leucyl, or valyl residue; in the fourth the asparaginyl group was replaced by a glutaminyl residue. Synthetic oxytocin and the international standard pituitary (posterior lobe) powder were used for comparison. Although the analogues showed marked differences in their oxytocic effects, there was a fairly good agreement between the results obtained on the isolated rat uterus and the blood pressure of the chicken for each polypeptide. The milk-ejection pressure test gave much higher values throughout. The pressor and antidiuretic activities of the four analogues showed no obvious correlation with the values obtained in the other tests. The valyl and the leucyl analogues also had a diuretic effect. The phenylalanyl analogue was remarkable for the close correspondence between its oxytocic and antidiuretic effects: practically identical values were obtained for the potency, whether measured on the rat uterus in vitro, the blood pressure in the chicken, the cat uterus in situ or water diuresis in the rat. The leucyl analogue showed an oxytocic activity on the cat uterus in situ or the rabbit mammary gland roughly 7 to 9 times as high as that measured by means of the conventional bioassay methods, such as the blood pressure of the chicken or the rat uterus in vitro. The glutaminyl analogue, the weakest of the whole series, had only a modest effect on the mammary gland. The valyl analogue was the most interesting of the new polypeptides. Its oxytocic action on the cat uterus in situ and its milk-ejecting effect were greater than that of synthetic oxytocin, whereas its antidiuretic and pressor effects were less. In cats and rats, the uterine effect was stronger in situ than in vitro. There were also distinct species differences between cats, rabbits, and rats in their sensitivity to valyl-oxytocin.

Entities:  

Keywords:  OXYTOCIN/related compounds

Mesh:

Substances:

Year:  1957        PMID: 13446374      PMCID: PMC1509676          DOI: 10.1111/j.1476-5381.1957.tb00121.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  10 in total

1.  Some observations on the contractile tissue of the mammary glands.

Authors:  J L LINZELL
Journal:  J Physiol       Date:  1955-11-28       Impact factor: 5.182

2.  [Effects of oxytocin on renal water and salt excretion in rats].

Authors:  H BRUNNER; G KUSCHINSKY; G PETERS
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1956

3.  [Antidiuretic and diuretic effects of synthetic oxytocin in water-diuresis experiments in rats].

Authors:  B BERDE; A CERLETTI
Journal:  Helv Physiol Pharmacol Acta       Date:  1956

4.  The cyclic disulfide ring of oxytocin.

Authors:  C RESSLER
Journal:  Proc Soc Exp Biol Med       Date:  1956 Aug-Sep

5.  Synthesis and biological activity of a new potent analogue of oxytocin.

Authors:  B BERDE; R A BOISSONNAS; S GUTTMANN; P A JAQUENOUD; H KONZETT; J P WALLER
Journal:  Nature       Date:  1956-08-04       Impact factor: 49.962

6.  [Syntocinon, a synthetic uterus-effective posterior pituitary hormone].

Authors:  H KONZETT; B BERDE; A CERLETTI
Journal:  Schweiz Med Wochenschr       Date:  1956-03-03

7.  [The effect of oxytocin on the diuresis and salt excretion in rats and men].

Authors:  H BRUNNER; G KUSCHINSKY; O MUNCHOW; G PETERS
Journal:  Klin Wochenschr       Date:  1956-04-15

8.  The action of pituitary extract upon the pregnant uterus of the rabbit.

Authors:  H H Knaus
Journal:  J Physiol       Date:  1926-06-22       Impact factor: 5.182

9.  A method of conducting a biological assay on a preparation giving repeated graded responses illustrated by the estimation of histamine.

Authors:  H O Schild
Journal:  J Physiol       Date:  1942-06-02       Impact factor: 5.182

10.  Influence of female hormones on motility of cat's uterus and its responses to oxytocics.

Authors:  M L CLARY; A CAMERON; B N CRAVER
Journal:  Proc Soc Exp Biol Med       Date:  1951-08
  10 in total
  15 in total

1.  The effect of oxytocin and vasopressin and of phenylalanyl 3-oxytocin on the urinary excretion of water and electrovtes.

Authors:  W B THOMSON
Journal:  J Physiol       Date:  1960-02       Impact factor: 5.182

2.  Renal excretion of hyaluronidase and calcium in man during the antidiuretic action of vasopressins and some analogues.

Authors:  S E DICKER; M G EGGLETON
Journal:  J Physiol       Date:  1961-07       Impact factor: 5.182

3.  Some pharmacological actions of synthetic analogues of angiotensinamide.

Authors:  T B PAIVA; A C PAIVA
Journal:  Br J Pharmacol Chemother       Date:  1960-12

4.  The vascular responses of the rat during the reproductive cycle.

Authors:  S LLOYD
Journal:  J Physiol       Date:  1959-10       Impact factor: 5.182

5.  Comparison of effects of valyl(3)-oxytocin and syntocinon on the cardiovascular system of man.

Authors:  A H KITCHIN; H KONZETT; M PICKFORD
Journal:  Br J Pharmacol Chemother       Date:  1959-12

6.  Effect of valyl-oxytocin on the human subject.

Authors:  C N SMYTH
Journal:  Br Med J       Date:  1958-04-12

7.  Laboratory and clinical studies of 2-phenylalanine-8-lysine vasopressin (octapressin).

Authors:  M E Hunter; R A Gordon
Journal:  Can Anaesth Soc J       Date:  1966-01

8.  Some pharmacological properties of oxytocin-dimers ( + ).

Authors:  B Berde; P A Jaquenoud; E Stürmer
Journal:  Experientia       Date:  1971

9.  [Quantitative comparative study of oxytocin and 5 related neurohypophysial peptides on the human uterus in situ].

Authors:  K Saameli
Journal:  Arch Gynakol       Date:  1965

10.  The biological activity of a new analogue of oxytocin in which the tyrosyl group is replaced by phenylalanyl.

Authors:  H KONZETT; B BERDE
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.